Preclinical and clinical CAR-T evaluation
Design, validate or accelerate clinical development with expert infrastructures.
Offer overview
What this offer helps you achieve
Design, validate or accelerate clinical development with expert infrastructures.
Scientific and technical scope
Clinical and preclinical evaluation of efficacy and toxicity of CAR-T cell (acute lymphoblastic leukemia / acute myeloid leukemia) treatments Preclinical and clinical evaluation of the efficacy and toxicity (pre-regulatory) of CAR-T cell therapy treatments. Combining expertise from the preclinical to the clinical stage, to assess the potential of the therapeutic solution.
Capabilities mobilised
Therapeutic areasValidation using preclinical modelsClinical validation
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
